Mirexus Biotechnologies

About:

Mirexus Inc. is a start-up company which is commercializing a novel “green” technology based on polysaccharide sub-micron particles that

Website: http://mirexus.com

Top Investors: GreenSky Ventures, Asahi Kasei, Goddard Enterprises

Description:

Mirexus Inc. is a start-up company which is commercializing a novel “green” technology based on polysaccharide sub-micron particles that can be used in a wide variety of applications, ranging from cosmetics to foods to architectural coatings to drug delivery in medicine. This technology was originally developed at the University of Guelph with financial support from the Ontario Centres of Excellence (OCE), the Advanced Foods and Materials Network (AFMNet), and the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA). Mirexus is currently seeking partnerships with industry to develop innovative products based on this technology.

Total Funding Amount:

$15.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shawnee On Delaware, Pennsylvania, United States

Founded Date:

2008-01-01

Contact Email:

acrumblehulme(AT)mirexus.com

Founders:

Anton Korenevski, Erzsebet Papp, John Dutcher, Oleg Stukalov

Number of Employees:

11-50

Last Funding Date:

2017-06-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai